Aromatherapy Inhalation in Psychiatric Nurses
The Effect of Aromatherapy Inhalation on the Therapeutic Relationship and Work Stress Levels of Psychiatric Nurses
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Serdar Türkyılmaz
- Phone Number: 05515540054
- Email: serdarturkyilmaz0752@gmail.com
Study Locations
-
-
Yenimahalle
-
Ankara, Yenimahalle, Turkey
- Ankara Etlik City Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Written permission was obtained before participating in the study
- Having worked in the psychiatry departments of the relevant institution for at least 1 year
- Working in the psychiatry departments of the relevant institution during the study dates
- Not sensitive to the odor of lavender essential oil
Exclusion Criteria:
- Previous experience with aromatherapy
- Sensitivity and allergy to lavender essential oil
- Willingly leaving the study while the study was ongoing
- Leaving the job during the study period
- General condition changes during the study period (developing allergies, getting sick, taking annual leave, taking leave with a health report)
- Becoming a service responsible nurse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental group
In this study, aromatherapy inhalation will be applied to psychiatric nurses in the experimental group.
Aromatherapy inhalation using 2% diluted lavender essential oil will be applied to 33 psychiatric nurses in the experimental group, 30 minutes before starting work, every other day during a week.
The "General Job Stress Scale (GJSS)" and "Therapeutic Relationship Evaluation Scale-Nurse Form (TRES-NF)" inventories will be filled out by 33 psychiatric nurses in the experimental group before and after aromatherapy inhalation, and by 33 psychiatric nurses in the control group simultaneously with the psychiatric nurses in the experimental group.
|
Aromatherapy inhalation using 2% diluted lavender essential oil will be applied to 33 psychiatric nurses in the experimental group, 30 minutes before starting work, every other day during a week.
The lavender essential oil to be used in the study will be dropped 3 drops onto a cotton handkerchief cut into a disc shape and fixed to the clothes of the psychiatric nurses, 20 cm away from their noses, and they will be asked to inhale it for 30 minutes.
|
|
No Intervention: Control group
There will be no training or intervention.
No intervention will be made to the 33 psychiatric nurses in the control group.
The psychiatric nurses in the control group will be asked to fill out the "General Job Stress Scale (GJSS)" and "Therapeutic Relationship Evaluation Scale-Nurse Form (TRES-NF)" inventories simultaneously with the 33 psychiatric nurses in the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
General Job Stress Scale (GJSS)
Time Frame: Change from before implementation, after practice is completed (1th week)
|
The Turkish validity and reliability of the scale developed by De Bruin (2006) to measure the general job stress of employees was provided by Teleş (2020).
The scale has a one-dimensional structure that addresses the emotional, cognitive, motivational and social consequences of job stress.
The scale, which has no sub-dimensions and consists of a five-point Likert-type and nine items, is stated as "1=Never, 2=Rarely, 3=Sometimes, 4=Mostly, 5=Always".
The total score to be obtained from the scale is a concrete expression of job stress and a high score to be obtained from the scale indicates that high job stress is experienced.
As a result of the validity and reliability study conducted by Teleş (2020), the Cronbach alpha coefficient of the scale was stated as 0.91 (De Bruin, 2006; Teleş, 2020).
|
Change from before implementation, after practice is completed (1th week)
|
|
Therapeutic Relationship Evaluation Scale-Nurse Form (TRES-NF)
Time Frame: Change from before implementation, after practice is completed (1th week)
|
Developed by Coelho et al. (2021) to assess the quality of the therapeutic relationship between psychiatric nurses and psychiatric patients, the Turkish validity and reliability of the scale was established by Duran and Polat (2023).
The scale, which consists of a five-point Likert type and 25 items, can be used in one dimension or with four subdimensions as "empathy, self-awareness, participation in care, and orientation".
The answers to each item in the scale are specified as "1=Never, 2=Rarely, 3=Sometimes, 4=Frequently, 5=Always".
It has been stated that a minimum of 25 and a maximum of 125 points can be obtained if the scale is used in one dimension.
It has been stated that if the scale is used in other subdimensions, 5-25 points can be obtained from the empathy subdimension, 6-30 from the self-awareness subdimension, 8-40 from the participation in care subdimension, and 6-30 from the orientation subdimension.
As a result of their validity and reliability study, Duran and Polat (
|
Change from before implementation, after practice is completed (1th week)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0009-0003-2884-5320
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.